nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0367	0.0633	CcSEcCtD
Paliperidone—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0286	0.0492	CcSEcCtD
Paliperidone—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0157	0.027	CcSEcCtD
Paliperidone—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0236	CcSEcCtD
Paliperidone—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0218	CcSEcCtD
Paliperidone—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0209	CcSEcCtD
Paliperidone—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0193	CcSEcCtD
Paliperidone—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0179	CcSEcCtD
Paliperidone—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0173	CcSEcCtD
Paliperidone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0164	CcSEcCtD
Paliperidone—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0161	CcSEcCtD
Paliperidone—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0087	0.015	CcSEcCtD
Paliperidone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00858	0.0148	CcSEcCtD
Paliperidone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00784	0.0135	CcSEcCtD
Paliperidone—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00779	0.0134	CcSEcCtD
Paliperidone—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0133	CcSEcCtD
Paliperidone—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00748	0.0129	CcSEcCtD
Paliperidone—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00646	0.0111	CcSEcCtD
Paliperidone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00643	0.0111	CcSEcCtD
Paliperidone—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00634	0.0109	CcSEcCtD
Paliperidone—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00631	0.0109	CcSEcCtD
Paliperidone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0106	CcSEcCtD
Paliperidone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00603	0.0104	CcSEcCtD
Paliperidone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00595	0.0102	CcSEcCtD
Paliperidone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0102	CcSEcCtD
Paliperidone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00587	0.0101	CcSEcCtD
Paliperidone—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00962	CcSEcCtD
Paliperidone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00955	CcSEcCtD
Paliperidone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00929	CcSEcCtD
Paliperidone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00882	CcSEcCtD
Paliperidone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00879	CcSEcCtD
Paliperidone—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00879	CcSEcCtD
Paliperidone—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00505	0.0087	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00867	CcSEcCtD
Paliperidone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00849	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00849	CcSEcCtD
Paliperidone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00832	CcSEcCtD
Paliperidone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00832	CcSEcCtD
Paliperidone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00815	CcSEcCtD
Paliperidone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00778	CcSEcCtD
Paliperidone—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00778	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00773	CcSEcCtD
Paliperidone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00768	CcSEcCtD
Paliperidone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00766	CcSEcCtD
Paliperidone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00757	CcSEcCtD
Paliperidone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0075	CcSEcCtD
Paliperidone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00746	CcSEcCtD
Paliperidone—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00723	CcSEcCtD
Paliperidone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00721	CcSEcCtD
Paliperidone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00721	CcSEcCtD
Paliperidone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00699	CcSEcCtD
Paliperidone—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00696	CcSEcCtD
Paliperidone—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00692	CcSEcCtD
Paliperidone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00678	CcSEcCtD
Paliperidone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00667	CcSEcCtD
Paliperidone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00662	CcSEcCtD
Paliperidone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00656	CcSEcCtD
Paliperidone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00621	CcSEcCtD
Paliperidone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00618	CcSEcCtD
Paliperidone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00588	CcSEcCtD
Paliperidone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0058	CcSEcCtD
Paliperidone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00571	CcSEcCtD
Paliperidone—Tension—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00569	CcSEcCtD
Paliperidone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00568	CcSEcCtD
Paliperidone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00563	CcSEcCtD
Paliperidone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00561	CcSEcCtD
Paliperidone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00557	CcSEcCtD
Paliperidone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00546	CcSEcCtD
Paliperidone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00543	CcSEcCtD
Paliperidone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00538	CcSEcCtD
Paliperidone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00536	CcSEcCtD
Paliperidone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00533	CcSEcCtD
Paliperidone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0053	CcSEcCtD
Paliperidone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00523	CcSEcCtD
Paliperidone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00521	CcSEcCtD
Paliperidone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00302	0.0052	CcSEcCtD
Paliperidone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00519	CcSEcCtD
Paliperidone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00512	CcSEcCtD
Paliperidone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00509	CcSEcCtD
Paliperidone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00506	CcSEcCtD
Paliperidone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00493	CcSEcCtD
Paliperidone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00493	CcSEcCtD
Paliperidone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00493	CcSEcCtD
Paliperidone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00492	CcSEcCtD
Paliperidone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00487	CcSEcCtD
Paliperidone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00483	CcSEcCtD
Paliperidone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00477	CcSEcCtD
Paliperidone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00473	CcSEcCtD
Paliperidone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00473	CcSEcCtD
Paliperidone—Shock—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00465	CcSEcCtD
Paliperidone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00463	CcSEcCtD
Paliperidone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00462	CcSEcCtD
Paliperidone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00451	CcSEcCtD
Paliperidone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00442	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00431	CcSEcCtD
Paliperidone—HTR2A—urine—nephrolithiasis	0.0025	0.103	CbGeAlD
Paliperidone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00428	CcSEcCtD
Paliperidone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00425	CcSEcCtD
Paliperidone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00422	CcSEcCtD
Paliperidone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00244	0.0042	CcSEcCtD
Paliperidone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00416	CcSEcCtD
Paliperidone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00411	CcSEcCtD
Paliperidone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00408	CcSEcCtD
Paliperidone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00404	CcSEcCtD
Paliperidone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00404	CcSEcCtD
Paliperidone—CYP3A4—urine—nephrolithiasis	0.00231	0.0952	CbGeAlD
Paliperidone—CYP2D6—urine—nephrolithiasis	0.00227	0.0937	CbGeAlD
Paliperidone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0039	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00387	CcSEcCtD
Paliperidone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00376	CcSEcCtD
Paliperidone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00374	CcSEcCtD
Paliperidone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00374	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00348	CcSEcCtD
Paliperidone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00339	CcSEcCtD
Paliperidone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00335	CcSEcCtD
Paliperidone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00324	CcSEcCtD
Paliperidone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00313	CcSEcCtD
Paliperidone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00301	CcSEcCtD
Paliperidone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00298	CcSEcCtD
Paliperidone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00298	CcSEcCtD
Paliperidone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00296	CcSEcCtD
Paliperidone—ADRA1B—renal system—nephrolithiasis	0.00168	0.0693	CbGeAlD
Paliperidone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00281	CcSEcCtD
Paliperidone—ADRA1B—kidney—nephrolithiasis	0.00163	0.067	CbGeAlD
Paliperidone—HTR1D—kidney—nephrolithiasis	0.00119	0.049	CbGeAlD
Paliperidone—HTR1A—renal system—nephrolithiasis	0.00102	0.0422	CbGeAlD
Paliperidone—ADRA2C—nephron tubule—nephrolithiasis	0.00099	0.0408	CbGeAlD
Paliperidone—ADRA1A—renal system—nephrolithiasis	0.000945	0.0389	CbGeAlD
Paliperidone—ADRA2C—renal system—nephrolithiasis	0.0009	0.0371	CbGeAlD
Paliperidone—ADRA2C—kidney—nephrolithiasis	0.00087	0.0359	CbGeAlD
Paliperidone—ADRA2C—cortex of kidney—nephrolithiasis	0.000848	0.0349	CbGeAlD
Paliperidone—CYP3A5—nephron tubule—nephrolithiasis	0.000829	0.0342	CbGeAlD
Paliperidone—CYP3A5—renal system—nephrolithiasis	0.000753	0.0311	CbGeAlD
Paliperidone—CYP3A5—kidney—nephrolithiasis	0.000728	0.03	CbGeAlD
Paliperidone—CYP3A5—cortex of kidney—nephrolithiasis	0.000709	0.0292	CbGeAlD
Paliperidone—ADRA2A—cortex of kidney—nephrolithiasis	0.000676	0.0279	CbGeAlD
Paliperidone—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000665	0.00168	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000663	0.00168	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000652	0.00165	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000652	0.00165	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000648	0.00164	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000648	0.00164	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000645	0.00163	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000639	0.00162	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000635	0.00161	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000634	0.00161	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000631	0.0016	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ADCY10—nephrolithiasis	0.000628	0.00159	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000621	0.00157	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000615	0.00156	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—DGKH—nephrolithiasis	0.000611	0.00155	CbGpPWpGaD
Paliperidone—HTR2A—renal system—nephrolithiasis	0.000611	0.0252	CbGeAlD
Paliperidone—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000609	0.00154	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000606	0.00153	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000606	0.00153	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000606	0.00153	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000605	0.00153	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000604	0.00153	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000598	0.00151	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000592	0.0015	CbGpPWpGaD
Paliperidone—HTR2A—kidney—nephrolithiasis	0.00059	0.0243	CbGeAlD
Paliperidone—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.00059	0.00149	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000585	0.00148	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00058	0.00147	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000576	0.00146	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000574	0.00145	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.000566	0.00143	CbGpPWpGaD
Paliperidone—CYP3A4—renal system—nephrolithiasis	0.000565	0.0233	CbGeAlD
Paliperidone—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000564	0.00143	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	0.000558	0.00141	CbGpPWpGaD
Paliperidone—CYP2D6—renal system—nephrolithiasis	0.000556	0.0229	CbGeAlD
Paliperidone—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000555	0.0014	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00055	0.00139	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00055	0.00139	CbGpPWpGaD
Paliperidone—CYP3A4—kidney—nephrolithiasis	0.000547	0.0225	CbGeAlD
Paliperidone—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000543	0.00137	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	0.000543	0.00137	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00054	0.00137	CbGpPWpGaD
Paliperidone—CYP2D6—kidney—nephrolithiasis	0.000538	0.0222	CbGeAlD
Paliperidone—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000535	0.00135	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—RGS14—nephrolithiasis	0.000534	0.00135	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000526	0.00133	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000525	0.00133	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000524	0.00133	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000521	0.00132	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000518	0.00131	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000516	0.00131	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000505	0.00128	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000504	0.00128	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000504	0.00128	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000496	0.00126	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000494	0.00125	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00049	0.00124	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000486	0.00123	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000486	0.00123	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000484	0.00123	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000481	0.00122	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000479	0.00121	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000479	0.00121	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.000475	0.0012	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000473	0.0012	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000471	0.00119	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000471	0.00119	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000463	0.00117	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000462	0.00117	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000458	0.00116	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000458	0.00116	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000457	0.00116	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000452	0.00114	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00045	0.00114	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00045	0.00114	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000449	0.00114	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000449	0.00114	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—PTH—nephrolithiasis	0.000445	0.00113	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000442	0.00112	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000441	0.00112	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000438	0.00111	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000432	0.00109	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000428	0.00108	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000427	0.00108	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000427	0.00108	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00042	0.00106	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000419	0.00106	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000419	0.00106	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000415	0.00105	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000414	0.00105	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000412	0.00104	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000412	0.00104	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000411	0.00104	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000409	0.00104	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000409	0.00103	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000408	0.00103	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—PTH—nephrolithiasis	0.000404	0.00102	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000401	0.00101	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.0004	0.00101	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.0004	0.00101	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000398	0.00101	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.000395	0.001	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000394	0.000997	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000392	0.000993	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00039	0.000988	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.000389	0.000984	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000382	0.000968	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000377	0.000953	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000375	0.000948	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000375	0.000948	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000375	0.000948	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000372	0.000941	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000367	0.000929	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000367	0.000929	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000364	0.000922	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.000364	0.000921	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000363	0.000919	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000363	0.000918	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000363	0.000918	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000361	0.000914	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—DGKH—nephrolithiasis	0.000361	0.000914	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.000359	0.000909	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000359	0.000908	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.000357	0.000905	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000357	0.000903	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000357	0.000903	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000356	0.000902	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000354	0.000897	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00035	0.000886	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000347	0.000877	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000344	0.000872	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000343	0.000867	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000342	0.000866	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00034	0.000861	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000333	0.000844	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000331	0.000838	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000331	0.000837	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000328	0.00083	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000326	0.000824	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000325	0.000824	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000325	0.000823	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000325	0.000823	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000325	0.000823	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000325	0.000822	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000324	0.00082	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000321	0.000812	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.000321	0.000812	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000319	0.000806	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000318	0.000804	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000313	0.000792	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.000311	0.000788	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.000303	0.000766	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000302	0.000766	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.0003	0.00076	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000298	0.000754	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000298	0.000753	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000297	0.000752	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000296	0.000749	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000295	0.000748	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000295	0.000746	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000295	0.000746	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000295	0.000746	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000291	0.000738	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000289	0.000733	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000289	0.000733	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000289	0.000732	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000279	0.000707	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000279	0.000707	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000278	0.000704	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000278	0.000704	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000275	0.000695	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000271	0.000686	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000271	0.000685	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00027	0.000684	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.00027	0.000684	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.00027	0.000684	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—APRT—nephrolithiasis	0.00027	0.000684	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.00027	0.000684	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.00027	0.000683	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000269	0.00068	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000266	0.000674	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000266	0.000674	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000265	0.000671	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000265	0.00067	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	0.000261	0.000661	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000258	0.000654	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000253	0.000641	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000248	0.000627	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000246	0.000622	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000245	0.000621	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000245	0.000621	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.000243	0.000614	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000241	0.000611	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000241	0.000611	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000241	0.00061	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000241	0.00061	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PTH—nephrolithiasis	0.000239	0.000604	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000236	0.000598	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000236	0.000598	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000235	0.000595	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000234	0.000592	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.000232	0.000587	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000226	0.000572	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00022	0.000556	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.00022	0.000556	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.000215	0.000544	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000212	0.000537	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.00021	0.000532	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000209	0.00053	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000202	0.000511	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000201	0.000509	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000195	0.000495	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000192	0.000487	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000192	0.000487	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000192	0.000486	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000192	0.000486	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000191	0.000485	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.00019	0.000481	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000185	0.000468	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000184	0.000465	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.000179	0.000453	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000177	0.000449	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000176	0.000445	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000175	0.000442	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000174	0.000441	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000174	0.000441	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000171	0.000433	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000166	0.000419	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000162	0.000411	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.00016	0.000404	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000159	0.000403	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000159	0.000402	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000156	0.000396	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000148	0.000374	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000145	0.000368	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000137	0.000346	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000126	0.000318	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000126	0.000318	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000124	0.000315	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000124	0.000313	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000122	0.000308	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SPP1—nephrolithiasis	0.00012	0.000303	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000108	0.000273	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SPP1—nephrolithiasis	0.000106	0.000269	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	9.61e-05	0.000243	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	9.28e-05	0.000235	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	9.23e-05	0.000234	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	8.97e-05	0.000227	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.94e-05	0.000226	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	8.83e-05	0.000224	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SPP1—nephrolithiasis	8.14e-05	0.000206	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.09e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	8.01e-05	0.000203	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SPP1—nephrolithiasis	8e-05	0.000202	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	7.85e-05	0.000199	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	7.29e-05	0.000185	CbGpPWpGaD
